Isn't the good news on this is that a cannabis friendly company is now a pharmaceutical company, where historically big Pharma has been a bit wary of cannabis due to its impact on other drug sales?
This news sets up an interesting challenge of a David v Goliath in regard to MJ pharmaceutical drugs. I usually bet on where the big money is, but I'll keep my holding here for now since this is worth watching over the short term...
News 
Market Data 
Discover 
